GFRA1 and breast carcinoma: In these cell lines, it has been consistently demonstrated that treatment with estradiol (E2) induces transcription of multiple RET signaling system components, including RET, GFRA1, and ARTN, suggesting a regulatory mechanism for RET’s functions in breast cancer.